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Enhanced antimicrobial effect of berberine in nanogel carriers 
with cationic surface functionality 
Mohammed J. Al-Awady, a,b Adelaide Fauchet,a Gillian M. Greenwaya and Vesselin N. Paunova*  
We report a strong enhancement of the antimicrobial action of berberine encapsulated into polyacrylic acid-based nanogels 
followed by further surface functionalisation with a cationic polyelectrolyte (PDAC). Due to the highly developed surface 
area, the nanogel carrier amplifies the contact of the berberine with the microbial cells and increases its antimicrobial 
efficiency. We show that such cationic nanogel carriers of berberine can adhere directly to the cell membranes and maintain 
much high concentration of berberine directly onto the cell surface. We demonstrated that the antimicrobial action of the 
PDAC-coated nanogel loaded with berberine on E.coli and C.reinhardtii is much higher than that of the equivalent solution 
of free berberine due to the electrostatic adhesion between positively charged nanogel particles and the cell membranes. 
Our results also showed a marked increase of their antimicrobial action at shorter incubation times compared with the non-
coated nanogel particles loaded with berberine at the same conditions. We attribute this boost in antimicrobial effect of 
these cationic nanocarriers due to their increased concentration on the cell membranes which sustains high concentration 
of released berberine causing cell death within much shorter incubation times. This study can provide a blueprint for 
boosting the action of other cationic antimicrobial agents by encapsulating them in nanogels carriers functionalised with a 
cationic surface layer. Our nanotechnology approach would lead to developing more effective wound dressings, disinfecting 
agents, antimicrobial surfaces, antiseptic and antialgal/antibiofouling formulations.
Introduction 
Engineered nanomaterials have been recognised for their 
potential to solve many challenges in the fields of 
environmental remediation,1 agriculture,2 food and health 
care.3 Drug delivery using nanocarriers is a rapidly developing 
field focused on transmitting optimal amounts of drugs to the 
desirable sites such as diseased/infected tissues, tumors, etc. 
while reducing unwanted side effects of the drugs on other 
tissues.4,5 The nanomaterials for drug delivery must be 
biocompatible, nontoxic, biodegradable and non-immunogenic. 
The most common drug delivery nanocarriers include 
liposomes, polymeric micelles and dendrimers, artificial DNA 
structures, and biodegradable scaffolds.6 Nanogels are cross-
linked polymeric nanoparticles7 produced by physically or 
chemically cross-linking polymer networks that swell in an 
aqueous solutions due to the absorption of water facilitated by 
the presence of hydrophilic groups such as ether, sulphate, 
hydroxyl and carboxyl groups which are present in polymer 
chains.8 Good biocompatibility is vital for nanocarriers used for 
drug delivery to avoid adverse biological responses at the 
molecular, cellular or organ levels when utilized.9-11  
Berberine (BRB) is a isoquinoline quaternary alkaloid  extracted 
from many kinds of medicinal plants such as Hydrastis 
canadensis, Berberis aristata, Coptis chinensis, Coptis rhizome, 
Coptis japonica, Phellondendron amurense, Phellondendron 
Chinese schneid.12,13 It has attracted wide attention as a 
therapeutic agent against hyperlipidemia, diabetes, metabolic 
syndrome, polycystic ovary syndrome, obesity, fatty liver 
disease, coronary artery disease14 gastroenteritis and has 
antimicrobial, antidiabetic and anti-inflammatory 
properties.13,15,16 Berberine employs several antimicrobial 
effects being a NorA substrate capable of gathering in bacterial 
cells and of binding both single and double-stranded DNA, thus 
causing bacterial death by DNA damage.12 It shows a weak 
activity against Gram-negative bacteria,12 but has more 
powerful effect against Gram-positive bacteria, such as 
Mycobacterium tuberculosis and MRSA (Methicillin-Resistant 
S.aureus), by the multi drug resistant (MDR) pump NorA 
inhibition.12,17,18 It also shows antifungal activity on Aspergillus, 
Penicillium, Candida and Cryptococcus13,16 and has an anti-
inflammatory activity.19  Several studies have been reported 
where berberine has been encapsulated in nanoparticles to 
form (berberine chloride-O-Hexadecyl-Dextran NPs) (BC-HDD 
NPs).  Upon incubation with glucose stressed hepatocytes, a 
decrease in recativ oxygen species (ROS) generation, oxidative 
stress and lipid peroxidation was detected in BC-HDD NPs 
treated cells in comparison with bulk berberine solution.20 Tsai 
et al. entrapped berberine into a chitosan hydrogel to design a 
transdermal delivery system for the treatment of cutaneous 
leishmaniasis.21  Chang et al. developed a novel nanocomposite 
with a heparin shell for berberine delivery to treat H. pylori.22 
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Figure 1. The schematic diagram for the encapsulation of berberine (from berberine hydrochloride) into polyacrylic nanogels by using swelling/deswelling cycle of the nanogel in the 
basic (pH 8) and acidic (pH 5) medium, respectively. The berberine-loaded nanogel was surface-functionalised with a cationic polyelectrolyte (PDAC). The chemical formulas of the 
carbomer nanogel (partially crosslinked polyacrylic acid), the PDAC and the bernerine are also presented. 
 
Lin et al. used berberine-loaded fucose-chitosan/heparin 
nanoparticles to obtain an enhanced suppressive effect when 
they interact with H.pylori and effectively reduce gastric 
inflammation in an H. pylori-infected animal study.23 Recently, 
a new anhydrous reverse micelle (ARMs) delivery system was 
successfully prepared for berberine for enhanced drug oral 
bioavailability and anti-diabetic efficacy.24 Berberine has also 
been shown to have enhanced anticancer efficacies through a 
solid lipid nanoparticle (SLN)-based delivery system 
demonstrated on MCF-7, HepG 2, A549 cancer cells25 and 
human hepatic carcinoma.26 In other studies, PLGA (polylactide 
glycolic acid) nanoparticles were prepared and loaded with 
berberine using single emulsion as well as multiple emulsion 
solvent evaporation techniques.27  Yeast cells of S.cerevisiae 
have also been used for encapsulating berberine as novel 
carriers for the food and drug industries.28 Likewise, berberine 
hydrochloride was encapsulated into alginate microspheres via 
an emulsification/gelation method.29 Other authors report the 
development of berberine-loaded chitosan/fucoidan-taurine 
nanoparticles as an epithelial protective material to prevent 
redistribution of TJ protein caused by bacterial endotoxin 
(LPS).30 Hydrogel composites also were prepared using a cross 
linking method with variable amounts of gellan gum and 
polyvinyl alcohol loaded with berberine and its functionalization 
to gold nanoparticles.31 
Recently, development of nanocarriers based on biodegradable 
materials attracted a lot of attention following concerns about 
the post-use fate of the nanocarrier formulations. Frangville et 
al.32 developed biodegradable nanoparticles of lignin using a 
solvent and pH change from Kraft lignin which showed no 
measurable toxicity against proxy organisms like yeast and 
microalgae. Richter et al. 33,42 utilised this biodegradable 
nanocarrier to propose a silver ion delivery system based on 
silver ion-loaded lignin nanoparticles which were further coated 
with cationic polyelectrolyte. The produced silver ion delivery 
vehicles proved to more potent antimicrobial agent for a range 
of bacteria than metallic silver nanoparticles. A range of other 
antimicrobial particles have recently been developed.43 Al-
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Awady et al.44 showed that the nanotoxicity of polyelectrolyte-
coated titania nanoparticles alternates with the surface charge 
with the particles with cationic outer layer (or bare titania 
nanoparticles) being much more toxic than the ones with an 
outer layer of anionic polyelectrolyte.  
In the present work, we expand these ideas to encapsulate 
berberine for antibacterial and antialgal applications by using 
Carbopol Aqua SF1 nanogels based on a partially cross-linked 
polyacrylic acid polymer. We study the stability of the 
berberine-loaded nanogel, its encapsulation efficiency, the 
controlled release of encapsulated berberine and the toxicity of 
the formed berberine-nanogel complexes and their cationic 
surface functionalised versions. Carbopol Aqua SF1 is an 
aqueous dispersion approximately 30% w/v of a lightly cross-
linked and highly hydrophilic polyacrylic nanogel which does not 
exhibit toxicity towards animal organs and a range of 
microorganisms.34  
Figure 1 explains the encapsulation steps of berberine into 
Carbopol Aqua SF1 and the surface functionalisation of the 
produced nanoparticles with a cationic polyelectrolyte. The 
conjugation of the nanogel and the berberine is based on 
electrostatic interaction with non-covalent bonding to ensure 
further releasing of the antimicrobial agent upon incubation of 
the loaded nanogel particles with the tested microorganisms. 
We characterised the produced berberine-loaded Carbopol 
nanogels (BLC) and detailed results are presented and discussed 
in the Electronic Supplementary Information (ESI). The main 
paper is concerned with the antibacterial and antialgal action of 
BLC on two proxy microorganisms, E.coli and C.reinhardtii 
respectively. We also explore the link between the berberine 
release kinetics and the boost of its antimicrobial action after 
coating of the BLC nanocarriers with a cationic polyelectrolyte. 
This approach has the potential to boost the action of other 
antimicrobial agents when encapsulated in cationic-surface 
functionalised nanocarriers. 
Materials and Methods 
Materials 
Deionised water purified by reverse osmosis and ion exchange 
from a Milli-Q water system (Millipore, UK) was used in all our 
studies. Its surface tension was 71.9 mNm-1 at 25°C, with 
measured resistivity less than 18 m Ω cm-1. Carbopol Aqua SF1 
aqueous suspension (30 wt%) was supplied by Lubrizol, USA. 
Poly(diallyldimethylammonium chloride) (PDAC) was supplied 
from Sigma Aldrich, UK. Berberine hydrochloride (98%) and 
fluorescein diacetate (FDA, 98%) was delivered by Fluka, UK. 
Chlamydomonas Reinhardtii (cc-124 strain) was sourced from 
Flickinger’s group at North Caroline State University, USA. This 
microalgae culture was grown in Tris-Acetate-Phosphate (TAP) 
culture medium with an incubation temperature of 30 oC. The 
culture media for C. reinhardtii consisted of TAP salts (NH4Cl; 
MgSO4.7H2O and CaCl2.2H2O), phosphate buffer solution (PBS) 
and Hutner’s trace elements solution (EDTA disodium salt, 
ZnSO4.7H2O, H3BO3, MnCl2.4H2O, CoCl2.6H2O, CuSO4.5H2O, 
FeSO4.7H2O, (NH4)6Mo7O24.4H2O, all purchased from Sigma-
Aldrich, UK. We used two different batches of cationic and 
anionic polyelectrolytes: poly(sodium 4-styrene sulfonate) 
sodium salt (PSS), M.W. 70 kDa and 10 kDa, respectively and 
poly(allylamine hydrochloride) (PAH), M.W. 15 kDa and 65 kDa, 
respectively, all purchased from Sigma Aldrich, UK. The 
microalgae batch was grown in the TAP media at pH 7 while 
being illuminated for 72 hours with a white luminescent lamp 
with a light intensity of 60 W m-2 under constant stirring with a 
magnetic stirrer.33,36 The stock cultures of C. Reinhardtti which 
were used for testing were with typical concentration 3.7 × 105 
cells per mL determined by automatic cell counter (Cellometer) 
and the E. coli bacterial culture stock was with approximately 
4.7 × 107 cells per mL. We found that the results from the 
antimicrobial testing of our nanocarriers were not sensitive to 
the exact cell concentration in the stock used over a wide range 
of values as the cell viability is determined as a relative value to 
the viability of the control system. 
Encapsulation of berberine into polyacrylic nanogel particles 
This procedure for preparation of BLC was done using a 
swelling/deswelling technique. Briefly, a 0.1 wt% Carbopol 
Aqua SF1 nanogel suspension was prepared by weighing 0.1 g 
of stock suspension and dispersed in a 20 ml Milli-Q water, then 
adjusted to pH 8 using 2 drops of 0.25 M NaOH. 75 ml of 0.2 
wt% of berberine hydrochloride solution was added to the 
nanogel suspension to prepare 0.15 wt% berberine in 0.1 wt% 
carbopol suspension. The produced BLC dispersion was stirred 
for 30 min and the pH was decreased to pH 5.5 using 2 drops of 
0.25 M HCl while stirring. After that the solution was 
centrifuged for 30 minutes at 8500 rpm. The supernatant was 
taken to measure the encapsulation efficiency of berberine in 
the nanogel and the BLC precipitate was washed twice in Milli-
Q water. Afterwards, the precipitate was dispersed in Milli-Q 
water and the pH of the solutions was increased to pH 8 using 2 
drops of 0.25 NaOH solution. The resulting solution was stirred 
overnight to make sure all the aggregated Carbopol solution 
had been allowed to swell at pH 8 and then the pH of the 
solution was decreased to pH 5 using acetate buffer solution. 
The total volume of BLC suspension was kept at 100 ml. 
Release kinetics of berberine from BLC 
It was investigated the percentage of in vitro berberine release 
using aliquots of equivalent concentrations of berberine-loaded 
0.1 wt% Carbopol. This formulation had already been optimized 
in terms of the encapsulation stability with particle size and zeta 
potential of the colloidal nanogel was 135 nm and -40 mV at pH 
5.5, respectively. The berberine-loaded nanogel suspension was 
placed into a dialysis cassette (10K MWCO, Thermo Fisher, UK) 
which allowed the berberine released from the nanogel to 
diffuse through its membrane pores. The dialysis device was 
placed into: (i) a beaker which was already pre-filled with 
acetate buffer solution (pH 5.5) or (ii) a beaker with a phosphate 
buffer at pH 7.5 in order to monitor the amount of released 
berberine at a specific pH. After that, the concentration of the 
released berberine in vitro was measured using UV-Visible 
spectrophotometer.  All release experiments were carried out 
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in triplicate. The percentage of cumulative drug release was 
calculated. 
Functionalisation of the nanogel particles with cationic 
polyelectrolytes 
Cationic polyelectrolyte was used to reverse the surface charge 
of Carbopol Aqua SF1 nanogel. PDAC solutions with a range of 
different concentrations (0.001-0.01 wt%) were mixed 
separately with a fixed concentration of the nanogel (0.1 wt%) 
at pH adjusted in the range to 4.75-5.00 using acetate buffer 
with the final volume of the suspension being 10 ml. The zeta 
potential was measured for each sample to find out the 
optimum concentration of both the cationic polyelectrolyte and 
the nanogel which in turn give stable suspension. 
Surface functionalization of BLC with PDAC 
A 1.10 ml aliquot of 0.2 wt% PDAC solution was rapidly added 
to a suspension of 10 ml of the BLC suspension with vigorous 
shaking and then diluted to 20 ml to form PDAC-coated 0.0075 
wt% berberine-loaded 0.05 wt% Carbopol Aqua SF1 nanogel 
dispersion (PDAC-coated BLC). The resulting solution was used 
as a stock to study its antimicrobial activity on C.reinhartti and 
E.coli. 
Cytotoxicity test of the non-coated nanogel particles 
A cell viability assay was performed to determine the 
cytotoxicity of the nanogel on both of C.Reinhardtii and E.coli. A 
0.3 wt% dispersion of Carbopol Aqua SF1 was prepared in a 100 
ml volumetric flask by dilution of an aliquot of the supplied 
stock with milli-Q water. The pH was adjusted to 5.5 using 
acetate buffer. 5 ml aliquots the cell suspension was washed 
from the culture media and incubated with a series of 5 ml 
aliquots of the nanogel dispersion of concentrations (0.01-0.15 
wt%) and tested at different incubation times. The control 
sample was treated in the same way without incubation with 
the nanogel. The cell viability was examined as described below. 
Cell viability assay protocol for C. Reinghardtti  
1 ml aliquots of the cell suspension were taken from each 
treated sample, centrifuged for 4 minutes at 3000 rpm and 
washed with Milli-Q water to remove the excess of the nanogel. 
The cells were re-suspended in 1 ml of Milli-Q water and treated 
with FDA cell viability assay as follows. Fluorescein diacetate 
(FDA) is a non-polar esterified compound which easily diffuses 
through the cell membranes.37,38 If the cell is viable and  its 
membrane is intact the hydrolysis of the non-fluorescent 
precursor (FDA) by intracellular esterase leads to accumulation 
of fluorescein.39 We used 0.5% w/v FDA dissolved in acetone. 20 
µL of this solution was used per mL of cell sample. The tube with 
the mixture was shaken for 10 minutes using a vortex at 1500 
rpm in dark conditions to avoid the photobleaching of the 
produced fluorescein inside the viable cells. The cells were 
washed three times with Milli-Q water using a centrifuge 
(Eppendorf Minispin plus) at 3500 rpm for 5 minutes in order to 
remove any extracellular fluorescein. The microalgae cell 
viability tests were carried out using an automatic cell counter. 
 Antimicrobial assay for aqueous solutions of free berberine 
We studied the biological activity of free berberine upon 
incubation with C.Reinhardtii and E.coli. 5 ml aliquots of the 
suspensions (washed from the culture media) were incubated 
with 5 ml aqueous solution of berberine hydrochloride of a 
series of concentrations (0.005-0.15 wt%) prepared and diluted 
with autoclaved Milli-Q water from 0.2 wt% stock solution at 
various incubation times. The control sample was kept under 
the same conditions but without berberine. After that, 1 ml 
aliquots of the suspended cells were taken from each treated 
sample, centrifuged for 4 minutes at 3000 rpm, washed to 
remove the supernatant and then re-suspended in 1 ml Milli-Q 
water. FDA live/dead viability assay was used as described 
above for C.Reinhardtii. E.coli cell viability was tested using 
BacTiter-Glo reagent followed by measurement of the relative 
luminescence of the sample (see below). 
Antialgal activity of BLC on C. Rinhardtii 
The activity of BLC towards C.reinhardtii was tested in 
suspension culture as follows. A 100 ml aliquot of 5 × 106 cells 
ml-1 of the C. reinhardtii culture was centrifuged out of the 
culture media, washed three times and re-dispersed with 50 ml 
Milli-Q water. 5 ml aliquots of 1×107 cells ml-1 suspension of 
washed C. reinhardtii microalgae cells were then incubated with 
a series of 5 ml aliquots of different equivalent concentrations 
of 0.15 wt% berberine-loaded 0.1 wt% Carbopol Aqua SF1 
suspension (0.01, 0.025, 0.05, 0.075, and 0.1 wt%). The cell 
viability was measured at different incubation times up to 6 
hours using the FDA live/dead assay.  
Antimicrobial activity of BLC on E.coli 
The activity of BLC towards E.coli was tested in suspension 
culture as follows. 50 ml of dispersed E.coli cells cultured in LB 
medium were washed three times and redispersed with 50 ml 
autoclaved Milli-Q water in 50 ml centrifuge tube. The relative 
luminescence unit for the culture media free cells was found to 
be 140 a.u. 5 ml aliquots of this cell dispersion were incubated 
with 5 mL BLC suspension of different equivalent overall 
concentrations of berberine. After each incubation, 1.0 ml of 
each E.coli suspension sample was washed and re-suspended in 
1 ml Milli-Q water. Then 100 µl of culture media-free E.coli cells 
was incubated with 100 µl of BacTiter-Glo microbial cell viability 
reagent in white opaque 96-well microplate solid flat bottom. 
The relative luminescence intensity was measured as a function 
of incubation time to find out the cell viability upon incubation 
with nanogel loaded with different concentrations of 
encapsulated berberine.  
Cytotoxic Effect of PDAC on C. Reinghardtti and E.coli 
We tested the toxicity of the cationic polyelectrolyte (PDAC) 
towards both C.reinghardtti and E.coli. A series of aqueous 
solutions of PDAC (0.0045-0.05 wt%) were incubated separately 
with 5 ml of each microorganisms culture dispersion and the cell 
viability was measured at different incubation times as 
described above. 
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Figure 2: The percentage of berberine release as a function of time for 0.15 wt% 
berberine-loaded in 0.1 wt% Carbopol (BLC). 
 
Cytotoxic effect of PDAC-coated nanogel on C. Reinghardtti and 
E.coli 
This procedure explains the cytotoxic effect of the PDAC-coated 
nanogel on C.reinghardtti and E.coli. 5 ml aliquots of PDAC-
coated nanogel suspension of each concentration (0.0018-
0.018 wt%) were incubated individually with 5 ml each 
suspension of C. Reinghardtti or E. coli. Then the cell viability 
was measured using the same assay. This experiment was done 
as a control to evaluate the antimicrobial activity of the PDAC-
coated nanogel carrier without a berberine load. 
Antimicrobial activity of PDAC-coated BLC nanogel 
We investigated the antimicrobial action of PDAC-coated BLC 
nanogel suspension on C.reinhardtti and E.coli as follows. 50 ml 
aliquots of each cell culture were centrifuged from the culture 
media, washed three times and re-dispersed in 5 ml autoclaved 
purified water. 250 µl aliquots of the washed cells were then 
incubated with 5 ml of series of diluted suspensions of the 
PDAC-coated BLC stock dispersion (PDAC-coated 0.0075 wt% 
berberine-loaded 0.05 wt% Carbopol Aqua SF1) whereby the 
cell viability was measured according to the protocols described 
above. For C.reinhardtti, we varied the PDAC-coated BLC 
concentrations from 0.0018 wt% PDAC-coated 0.0015 wt% BLC 
suspension to 0.0045 wt% PDAC-coated 0.00375 wt% 
berberine-loaded nanogel complex. For E.coli the concentration 
range was from 0.0022 wt% PDAC-coated 0.0015 wt% BLC to 
0.0088 wt% PDAC-coated 0.006 wt% BLC nanogel. 
 
Protocol for SEM imaging of the treated cells 
The cells (microalgae or E.coli) were washed from their culture 
media using PBS, adhered to Aclar film, fixed in 2.5 wt% 
glutaraldehyde in 0.1M cacodylate buffer pH 7.2 for 2 hours at 
room temperature, rinsed three times with cacodylate buffer, 
post fixed in 1 wt% osmium tetroxide in cacodylate buffer for 
one hour, rinsed in cacodylate buffer, dehydrated in series of 
ethanol-water solution with decreasing water content up to 
100% ethanol and then dried using liquid carbon dioxide in a 
critical point dryer.   
Results and Discussion 
Encapsulation of berberine into Carbopol Aqua SF1 nanogel 
The strategy behind the swelling/deswelling technique is to 
allow berberine cations to infuse the core of the nanogel 
particles through increasing pH of the nanogel suspension up to 
8. At this pH, the nanogel particles are swollen and the carboxyl 
groups of the polyacrylic acid more deprotonated which allows 
the berberine cations to interact with them. The pH drop to 5.5 
causes shrinkage of the BLC nanogel. The berberine-loaded 
nanogel at pH 5.5 was centrifuged to remove the free 
berberine. To avoid precipitate in this process, the pH of the 
berberine-loaded nanogel was raised to pH 8 so that the 
particles swell and disperse again followed by de-swelling at pH 
5.5 using acetate buffer. This procedure yielded fully dispersed 
and stable suspension of berberine-loaded Carbopol nanogel. In 
the ESI we present a detailed study of the swelling behaviour of 
the Carbopol nanogel before and after loading with berberine. 
The collapsed (not-loaded) nanogel particles have an average 
diameter of about 100 nm at a pH below 6.8 and swell very 
sharply to approximately 330 nm just above pH 6.8. After 
loading with berberine at pH 8 and then collapsing at pH 5, the 
size of the BLC particles is about 130 nm (c.f. Figures S3 and S9).  
The overall swelling is attributed to the increase of the 
dissociation of the carboxyl groups of the nanogel which in turn 
caused electrostatic repulsion among them and expands the 
nanogel matrix. This facilitates the release of the previously 
entrapped berberine out in the surrounding medium. Both the 
non-loaded Carbopol nanogel and the BLC have a negative 
surface charge in their collapsed state which is preventing them 
from adhering to the negatively charged cell walls. In the ESI we 
present a range of UV/vis and FTIR spectroscopy studies of the 
BLC nanogel which confirm the presence of approximately 10% 
berberine in the particle cores. We present data on the BLC 
particle size upon coating with different cationic 
polyelectrolytes (see Figures S10 and S13).  
BLC can slowly release berberine upon dilution (see Figure 2). It 
can be observed that the berberine release depends on the pH 
of the medium. At pH 5.5, approximately 25% of the 
encapsulated berberine was released in 2 hours and then the 55 
% was released after 5 hours. After this the % released levelled 
off with only a slight increase of 65% after 24 hours. The slow 
release at pH 5.5 occurred due to the high zeta potential value 
of the anionic Carbopol nanogel at that pH which allowed delay 
in the release of the berberine cations out of the nanogel.  
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Figure 3. The viability of C. reinhardtii cells incubated with aqueous solutions of different 
concentrations of free berberine hydrochloride at different incubation times. The pH of 
the solution was adjusted with acetate buffer solution (pH 5.5). 
 
At pH 7.5, there is a more dramatic release of 86 % berberine 
up to 3 hours and 90% after 24 hours. This due to the decrease 
in the zeta potential value at pH 7.5 which means the berberine 
becomes unconjugated from the carboxyl groups of Carbopol. 
One possible explanation of this result is that at pH 5.5 the 
berberine is trapped inside the collapsed nanogel particles 
which ensure slower release than at pH 7.5 where the nanogel 
is swollen. At pH 5.5 only ~60% of the berberine is released over 
6 hours due to the strong interaction between the entrapped 
berberine cations and the anionic carboxyl groups of the 
nanogel. At higher pH, the percentage of the released berberine 
is significantly higher as the nanogel particle swell.  
 
 
Figure 4. The viability of C. reinhardtii cells incubated with solutions of series of different 
overall concentration of BLC after different incubation times. 
 
Figure 5. SEM images of C.reinhardtii cells after incubation with 0.01 wt% BLC whereby 
(A) represents the control sample and (B) show a typical image of an incubated cell with 
0.01 wt% BLC after 2 hours. 
 
Cytotoxicity assay of the non-coated nanogel carrier 
Cytotoxic assays were conducted through the incubation of 
suspensions of different concentrations of nanogel particles 
with two test microorganisms: C.reinhardtii (microalgae) and 
E.coli. The cells were removed from the culture media to avoid 
any interaction between the nanogel particles and the 
components of culture media. Our data presented on Figure S20 
(ESI) show no cytotoxic effect of Carbopol Aqua SF1 nanoogel 
without any antimicrobial additives on C. reinhardtii and upon 
for a wide range of Carbopol Aqua SF1 concentrations at room 
temperature and up to six hours of incubation. Figure S21 (ESI) 
also shows no pronounced cytotoxic effect of the bare nanogel 
particles on E.coli cells for up to 24 hours. These results indicate 
that the nanogel particles do not affect the viability of these 
microorganisms over the duration of the experiments. Our 
results are also in agreement with the technical data sheet 
provided by the manufacturer for other microorganisms.34  
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Figure 6. The relative luminescence intensity representing the E.coli viability of as a 
function of the concentration free berberine hydrochloride for 2 hours incubation time. 
 
 
Figure 7.  The relative luminescence intensities representing 
the viability of E.coli cells as a function of overall concentration of BLC for different 
incubation times. 
 
The morphology of C. reinhardtii after incubation with the 
nanogel was studied by TEM. Figure S22 in ESI shows the TEM 
images of microalgae cells incubated for 24 hours with 0.1 wt% 
Carbopol nanogel at pH 5.5. As seen in Figure S22B, the cell 
organelles of the microalgae seem more or less intact without 
visible disruption in the cell microstructure compared with the 
control sample as shown in Figure S22A. These results also 
suggest that nanogel does not have detectable effect at 
concentrations up to 0.1 wt% on the microalgae.  
Antialgal activity of BLC on C. reinhardtii 
We compared the antialgal activity of free berberine and the 
BLC on C. reinhardtii. The microalgae cells were separated from 
the culture media before incubation with series of solutions of 
free berberine and BLC of different concentrations. The cell 
viability was assessed after a range of incubation periods 
followed by removal of the cells from the tested solution. Figure 
3 shows the cell viability of the microalgae as a function of free 
berberine concentration. The viability of the microalgae 
immediately upon incubation (0 hours) gradually declined from 
low to high berberine concentrations, (85% at 0.001 wt% to 
around 10% at 0.05 wt%). Zero incubation time corresponds to 
the cells mixed with the berberine hydrochloride solution 
followed by immediate washing (within 5 min) and viability 
testing with FDA assay. After 2 hours of incubation the cells 
viability sharply decreased in comparison with the control 
sample with 0.05 wt% being the minimal concentration of free 
berberine hydrochloride which kills all the cells, 5% viable algal 
cells were found at a concentration of 0.01 wt% berberine after 
2 hours incubation time. After 4 hours of incubation, the 
viability was reduced to 20% at 0.001 wt% berberine 
concentration and by 6 hours incubation time, no viable cells 
were observed at concentrations of berberine hydrochloride 
from 0.007 wt% to 0.05 wt%.  The cell viability went down to 
15% at 0.001 wt% berberine. This demonstrates that free 
berberine hydrochloride tends to be an effective antialgal agent 
at moderate concentrations over a sufficiently long incubation. 
Figure 4 shows the viability of the C.reinhardtii after incubation 
with BLC dispersions of different concentrations at room 
temperature for up to 2 hours.  
One can see that the cell viability decreased slightly up to 0.005 
wt% BLC and then gradually declined from 0.0075 wt% to 0.01 
wt% of BLC at zero incubation time. After 1 hour incubation time 
the cell viability was reduced progressively from 60% to 20% at 
0.01 wt% average encapsulated berberine. After 2 hours, 
however, the cell viability decreased sharply from 37% at 0.001 
wt% to 7% viability at 0.0025 wt% BLC, respectively. At BLC 
concentrations above 0.01 wt% the cells complete lost their 
viability. The accumulation of free berberine cations at the cell 
membrane causes its opening and leads to the cell death. 
Comparing the activity of free berberine hydrochloride (Figure 
3) to this for BLC (Figure 4) one may conclude that the berberine 
encapsulation in the non-surface functionalised nanogel 
appeared to slightly decrease the antialgal activity of berberine. 
The encapsulated berberine in BLC is not completely released in 
1-2 hours (see Figure 2), therefore there is lower overall 
concentration of released bernerine cations around the cell 
walls compared with case when the cell are treated with the 
same overall concentration of free berberine. In this case the 
BLC is negatively charged and does not adhere to the negatively 
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charged the cell walls, hence they are targeted only berberine 
released in the bulk of the solution. 
 
Figure 8. SEM images for E.coli cells incubated with a suspension of 0.01 wt% BLC. (A) 
Control sample and (B, C, D) represent E.coli cells incubated with 0.01 wt% BLC at room 
temperature after 24 hours incubation time. 
 
Figure 5 shows SEM images of C. reinhardtii cells taken after 
incubation with 0.01 wt% BLC for 2 hours. It can be seen that 
the morphology of the cells had changed significantly and 
irregular membrane shapes as well as the detachment of the 
flagella for the treated microalgae cells appear (see Figures 5B, 
5C, and 5D) in comparison with the control sample (Figure 5A). 
Other authors have also reported similar change in the cell 
morphology for different antialgal agents which in our case 
could potentially be attributed to the interaction between the 
cell membrane and the BLC as endocytic cargos using 
clathrin/actin mediated-endocytosis.40 Note the size of the 
dimples left on the membrane of the treated cells corresponds 
approximately to the size of the collapsed BLC nanogel particles. 
However, TEM and SEM imaging of these samples show no 
experimental evidence of internalisation of the BLC particles by 
endocytosis. 
Antimicrobial activity of BLC on E.coli 
We also studied the antimicrobial activity of free berberine and 
BLC on E.coli at various incubation times. The data presented in 
Figure 6 show that free berberine also has a strong effect on the 
viability of the E. coli. The cell viability decreased at free 
berberine concentrations from 0.01 wt% to 0.1 wt% in the 
moment of addition of the cells to the solutions (0 hour 
incubation time). After 1 hour of incubation, the E.coli viability 
became much lower in comparison with the control sample. 
Similarly, at 2 hours incubation time about 95% of the E.coli cells 
were killed at 0.075 wt% and 0.1 wt% free berberine, 
respectively. The results for the antimicrobial activity of BLC on 
E.coli are shown in Figure 7. Surprisingly, BLC showed lower 
antimicrobial activity against E.coli than free berberine at the 
same overall berberine concentration. One possible reason 
could be the thicker cell wall of E.coli which makes it less 
sensitive to berberine than C.reinhardtii (c.f. Figures 3 and 4). 
For up to 4 hours incubation BLC showed very low antibacterial 
activity. For incubation times up to 8 hours, the antimicrobial 
activity increased from 30 % at 0.001 wt% to 70% at 0.01 wt% 
of overall encapsulated berberine (in BLC). After 24 hours of 
incubation, the viability of the E.coli sharply decreased to less 
than 5% at 0.01 wt% of overall concentration of BLC. The 
difference in the activity of free berberine and BLC is attributed 
to the slower rate of berberine release from the BLC. In addition 
to that, the collapsed nanogel particles at pH 5.5 have a 
relatively high negative zeta potential which retains the cationic 
berberine. In addition, the negatively charged BLC particles is 
likely to repel from the negatively charged surface of the E.coli 
cell wall which seems to reduce the effectiveness of the local 
berberine release in the cells near vicinity.  SEM images of E.coli 
cells after incubation with 0.01 wt% BLC suspension for 24 hours 
(Figure 8) show that the cells have some dimples and cavities on 
their surface which are absent on non-treated cells. This is due 
to the interaction between the cell membrane and berberine 
cations released from BLC particles which have been it their 
vicinity. Part of the BLC particles may also be internalized into 
the cells via endocytosis41 where this pathway is similar to that 
discussed for C. reinhardtii.  
Antimicrobial activity of the PDAC-coated nanogel 
Our experiments on the antimicrobial action of encapsulated 
berberine on E.coli showed that BLC has lower antimicrobial 
activity in comparison with free berberine hydrochloride. The 
main reason for this is that the nanogel particles retain their 
negative surface charge even after the encapsulation of the 
berberine in their cores. Our characterisation study presented 
in the ESI show that only one berberine molecule per 33 
carboxylic groups is absorbed in the core of the nanogel 
particles. The result of this is that the BLC has a negative zeta 
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potential (-40 ± 5 mV) similar to the non-loaded nanogel (see 
Figure S2 in ESI for more details). 
 
 
 
Figure 9. The cytotoxic effect of solutions of different PDAC concentration on (A) C. 
Reinhardtti and (B) E.coli for up to 1 hour incubation time at room temperature. 
Solutions of different PDAC concentrations were incubated with a fixed amount of E.coli. 
 
The electrostatic repulsion of the BLC particles with the 
negatively charged cell surface does not allow them to 
accumulate in near vicinity of the cell membrane and release 
the encapsulated antimicrobial agent. To overcome this 
problem, the nanogel particles were coated with a cationic 
polyelectrolyte PDAC to reverse their surface charge to positive 
which was expected to increase their adhesion to cells and 
potentially boost their antimicrobial action. 
To differentiate between the cytotoxic action of the berberine 
and this of PDAC-coated carrier we studied the effect of the 
PDAC alone on C.reinhardtii and E.coli. This was achieved by 
incubating E.coli. with solutions of different concentrations of 
PDAC to determine its threshold of cytotoxicity on these 
microorganisms. Figures 9A and 9B show the effect of aqueous 
solutions of PDAC of different concentrations on C.reinhardtii 
and E.coli, respectively. Note that the free cationic 
polyelectrolyte PDAC inn aqueous solution has an extremely 
strong antimicrobial effect in a wide range of concentrations 
ranging from 0.0045 wt% to 0.05 wt%.  
 
 
Figure 10. Cytotoxic effect of PDAC-coated nanogel upon incubation with microalgae 
cells for 2 hours at room temperature. 
 
Figure 11. The cytotoxic effect of dispersions of various concentrations of PDAC-coated 
nanogel (without berberine) on E.coli for 2 hours incubation at room temperature. The 
relative luminescence is proportional to the cell viability. 
 
Cytotoxicity of PDAC-coated nanogel on C.reinhardtii and E.coli 
In order to measure the antimicrobial activity of PDAC-coated 
and BLC on microalgae and E.coli, the cytotoxic effect of PDAC 
coated-Carbopol Aqua SF1 (without berberine) towards these 
microorganisms was investigated. The free PDAC was removed 
from the nanogel suspension before incubation with cells to 
differentiate between the cytotoxic effect of PDAC and the 
PDAC-coated nanogel. A fixed amount of each cell culture was 
incubated at room temperature with suspensions of varying 
concentrations of PDAC-coated Carbopol Aqua SF1 nanogel for 
several incubation times. Figure 10 shows the results for C. 
reinhardtii where there is little effect until 0.009 wt% to 0.018 
wt% at which point the viability is strongly affected.  In this 
range even a 0h (5 min) incubation time, the PDAC-coated 
nanogel particles appear to be toxic for the thin cell membrane 
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of this microalgae without any loaded berberine. The cytotoxic 
effect of PDAC-coated nanogel particles was also examined on 
E.coli. 
 
Figure 12. The viability of C. reinhardtii upon incubation with solutions of different 
concentrations of PDAC-coated BLC. The solutions were prepared depending on dilution 
from stock solution with the concentration 0.009 wt% PDAC-0.0075 wt%-0.075 wt% BLC 
suspension for different incubation times (5 min, 1h and 1.5h). The cells are washed from 
the nanogel suspension and their viability determined by the FDA live/dead cell assay. 
 
Figure 11 shows that PDAC-coated nanogel in the concentration 
range 0.0036-0.009 wt% was not toxic with up to a 2 h 
incubation time while at 0.018 wt% PDAC (coated on the 
nanogel) concentration there was a cytotoxic effect on E.coli. 
Therefore, for our experiments with PDAC-coated BLC we used 
PDAC concentrations from 0.0036 wt% to 0.009 wt% which by 
themselves are not-toxic for both microorganisms. This allowed 
us to evaluate the effect of the encapsulated berberine when 
the nanogel particle had been converted to cationic (positive 
zeta-potential) due to the PDAC coating. 
Antimicrobial activity of PDAC-coated BLC on C.reinhardtii 
We studied the antimicrobial activity of BLC additionally coated 
with PDAC to enhance the electrostatic adhesion between the 
negatively charged cell membrane and positively charged 
PDAC-coated BLC particles. Figure 12 shows the viability of 
C.reinhardtii incubated with suspensions of different 
concentration of PDAC-coated BLC. Here and hereafter the 
overall concentration of encapsulated berberine in the BLC 
suspension is quoted in the formulations. At 0 hours incubation 
time (instant exposure), the viability of the microalgal cells 
decreased from 82% at 0.0018 wt% PDAC-0.0015 wt% BLC 
concentration to 50% at 0.0045 wt% PDAC-0.00375 BLC 
formulation and then sharply declined to 15% at 0.0045 wt% 
PDAC-0.00375 wt% BLC. Upon increasing the incubation time to 
1.5 hours, all the cells died for 0.0045 wt% PDAC-0.00375 wt% 
BLC formulation while the viability was 7% for the 0.003 wt% 
PDAC-0.0025 wt% BLC. However, 40% of algal cells were viable 
after 1.5 hour for the 0.0018 wt% PDAC-0.0015 wt% BLC. 
Therefore, the combination of 0.0045 wt% PDAC-0.00375 wt% 
BLC was the most effective concentration to kill algal cells after 
1.5 hour incubation time.  
 
 
Figure 13. SEM images of C.reinhardtii microalgae cells. (A) Control sample of the 
microalgae cells. (B, C, D and E) C.reinhardtii cells incubated with 0.0045 wt% PDAC-
coated 0.00375 wt% BLC after one hour incubation time at room temperature. The 
experiment was conducted through incubation a suspension of microalgae cells with 
solution of PDAC-coated 0.00375 wt% BLC particles.  
 
Figure 13 shows SEM images for C.reinhardtii cells that had 
incubated with 0.0045 wt% PDAC-coated 0.00375 wt% BLC for 
1 hour. The images on Figure 15B, 15C, and 15D suggest that 
the microalgae cells were completely damaged by this cationic 
surface-functionalised berberine-nanogel complex and acquire 
an irregular shape in comparison with the control sample (see 
Figure 13A). The reason for this is due to the electrostatic 
interaction between the cationic PDAC-coated BLC and the 
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anionic cell membrane allows the adhering particles to release 
berberine in the local vicinity of the cell surface causing the 
membrane disruption.  
 
 
 
Figure 14. The viability of C. reinhardtii microalgae cells upon incubation with 0.0045 wt% 
PDAC, 0.0045 wt% PDAC-coated Carbopol, 0.0375 wt% free berberine, 0.00375 wt% BLC, 
and 0.0045 wt% PDAC-coated 0.00375 wt% BLC suspension for different incubation 
times (5 min, 1h and 1.5h). After incubation, the cells were washed from the respective 
formulation and their viability determined by the FDA live/dead cell assay. 
 
Figure 14 represents a comparison between the antimicrobial 
activities of PDAC-coated BLC, free berberine and BLC. More 
than 90% of algal cells were killed upon instant incubation (o 
hours) with 0.0045 wt% PDAC. However, at the same 
concentration of PDAC which had been used to coat the, there 
was no toxic effect without a berberine load. The BLC showed 
lower antimicrobial activity than free berberine (0.00375 wt%) 
which kills the cells after 1.5 h of incubation time as its release 
is slow from the core of the nanogel particles. In the latter case 
there is also a repulsion between the BLC and the cell 
membrane as they both carry negative surface charge. There 
was, however, an increase in the antimicrobial activity for the 
encapsulated berberine in the PDAC-coated nanogel compared 
with the uncoated BLC. The PDAC-coated BLC are cationic 
particles and in aqueous media they are strongly attracted to 
the negatively charged cell walls, allowing high local 
concentrations of released berberine to disrupt the cell 
membranes and kill the cells.  
Antimicrobial activity of PDAC-coated BLC on E.coli 
The antimicrobial activity of PDAC-coated BLC with E.coli was 
investigated by incubation of solutions of various concentration 
of PDAC coated BLC with a fixed amount of E.coli cells removed 
from their culture media for two hours at room temperature.  
 
 
Figure 15. The antibacterial activity of suspensions of different concentrations of (PDAC-
coated BLC against E.coli. The solutions were prepared from the stock solution (0.011 
wt% PDAC-coated 0.0075 wt% berberine-loaded 0.05 wt% nanogel).   
 
Figure 15 shows that there was no noticeable antimicrobial 
activity for berberine concentrations from 0.0015 wt% to 
0.0025 wt%. However, antimicrobial activity was seen for 
concentrations of 0.00375 wt% to 0.006 wt% berberine after 
two hours of incubation. Suspensions with 0.0088 wt% PDAC-
coated 0.006 wt% BLC appeared to have high antimicrobial 
activity towards E. coli. This increase in the antimicrobial 
efficiency was attributed to the increase in the concentration of 
berberine encapsulated into the nanogel carriers as well as the 
electrostatic attraction between PDAC-coated BLC and the 
outer cell membrane of E.coli, similarly to the microalgae, as 
discussed earlier. This is confirmed by the SEM images of the 
E.coli in Figure 16 that were incubated with 0.0088 wt% PDAC-
coated 0.006 wt% BLC for two hours at room temperature. It 
can be seen from Figures 16B and 16C that particles of PDAC-
coated BLC are clustered on the surface of the cell membrane 
of E.coli cells compared with control sample where there was 
no berberine involved (see Figure 16A). This aggregation occurs 
due to the electrostatic attraction between the cationic PDAC-
coated BLC particles and the anionic cell membrane of E.coli 
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which contributed to the strong boost of the antibacterial 
activity of berberine in comparison with the same 
concentration of free berberine over the same period of 
incubation. 
 
Figure 16. SEM images of E.coli cells. (A) Control sample of E.coli and (B, C, and D) 
incubation of E.coli cells with solution of 0.0088 wt% PDAC-coated 0.006 wt% BLC 
suspension.  
 
Conclusions 
We developed a novel surface functionalized nanocarrier for 
berberine by using polyacrylic acid based nanogel particles 
(Carbopol Aqua SF1) coated with a cationic polyelectrolyte 
(PDAC) which shows a strong boost of the berberine 
antimicrobial action. The latter was studied on C.reinhardtii 
microalgae and E.coli for berberine-loaded nanogel (BLC) 
coated with the cationic polyelectrolyte (PDAC-coated BLC).  
We demonstrated that the cationic coating of the nanogel 
increase strongly the antimicrobial action of the berberine 
against both C.reinhardtii and E.coli even for very short 
incubation times. The increase in the antimicrobial activity was 
attributed to the favourable electrostatic adhesion between the 
cationic PDAC-coated BLC and the anionic cell membranes 
allowing accumulation of BLC particles on the cell walls and local 
release of concentrated berberine causing the cell death. SEM 
images confirmed the aggregation of these cationic PDAC-
coated berberine-loaded nanogel on the surface of the cell 
membranes for both C.reinhardtii and E.coli. This 
nanotechnology inspired approach can be potentially applied to 
boost the antimicrobial action for a range of low-molecular 
weight antimicrobial and antialgal agents by using cationic 
surface-functionalised nanogel carriers. Similar strategy could 
also find applications for enhancing the action of topical 
antibiotics and antifungal agents and may be used to bypass 
antimicrobial resistance. 
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